522 related articles for article (PubMed ID: 17316677)
1. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD
J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
[TBL] [Abstract][Full Text] [Related]
2. [The effect on electrocardiographic and cardiac autonomic function after percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy].
Xing YB; Guo HY; Wang P; You BQ; Chen JZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):731-4. PubMed ID: 17963633
[TBL] [Abstract][Full Text] [Related]
3. Long-term electrocardiographic findings in patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
Haghjoo M
J Electrocardiol; 2007 Oct; 40(4):357.e1-2. PubMed ID: 17599476
[No Abstract] [Full Text] [Related]
4. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
[TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Kazmierczak J; Kornacewicz-Jach Z; Kisly M; Gil R; Wojtarowicz A
Heart; 1998 Sep; 80(3):257-62. PubMed ID: 9875085
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
[TBL] [Abstract][Full Text] [Related]
7. Quantitative and qualitative changes in the resting electrocardiograph after percutaneous transluminal septal myocardial ablation for the treatment of symptomatic obstructive hypertrophic cardiomyopathy.
Thai WE; Antonis PR; Hope SA; Meredith IT
Heart Lung Circ; 2008 Oct; 17(5):364-9. PubMed ID: 18657474
[TBL] [Abstract][Full Text] [Related]
8. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
9. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Zhang W; Li Z; Zhang M; Yuan L; Guan R; Hou A; Jin Y; Deng Z
Chin Med J (Engl); 2002 Sep; 115(9):1283-6. PubMed ID: 12411095
[TBL] [Abstract][Full Text] [Related]
10. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy.
Lawrenz T; Lieder F; Bartelsmeier M; Leuner C; Borchert B; Meyer zu Vilsendorf D; Strunk-Mueller C; Reinhardt J; Feuchtl A; Stellbrink C; Kuhn H
J Am Coll Cardiol; 2007 Jun; 49(24):2356-63. PubMed ID: 17572252
[TBL] [Abstract][Full Text] [Related]
11. Delayed injury of autonomic nerve induced by radiofrequency catheter ablation.
Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD
J Electrocardiol; 2007 Oct; 40(4):355.e1-4. PubMed ID: 17292382
[TBL] [Abstract][Full Text] [Related]
12. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
Seggewiss H; Faber L; Ziemssen P; Gleichmann U
Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
[TBL] [Abstract][Full Text] [Related]
13. Cardiac electromechanical mapping in analyzing the mechanism of left ventricular remodeling immediately after percutaneous transluminal septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Chen SL; Huang J; Ye F; Shan SJ; Zhang JJ; Duan BX; Chen YD
Chin Med J (Engl); 2005 Nov; 118(21):1779-85. PubMed ID: 16336814
[TBL] [Abstract][Full Text] [Related]
14. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome.
Veselka J; Procházková S; Duchonová R; Bolomová-Homolová I; Pálenícková J; Tesar D; Cervinka P; Honek T
Catheter Cardiovasc Interv; 2004 Oct; 63(2):231-5. PubMed ID: 15390343
[TBL] [Abstract][Full Text] [Related]
15. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.
Talreja DR; Nishimura RA; Edwards WD; Valeti US; Ommen SR; Tajik AJ; Dearani JA; Schaff HV; Holmes DR
J Am Coll Cardiol; 2004 Dec; 44(12):2329-32. PubMed ID: 15607394
[TBL] [Abstract][Full Text] [Related]
16. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.
van der Lee C; ten Cate FJ; Geleijnse ML; Kofflard MJ; Pedone C; van Herwerden LA; Biagini E; Vletter WB; Serruys PW
Circulation; 2005 Jul; 112(4):482-8. PubMed ID: 16027255
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
[TBL] [Abstract][Full Text] [Related]
19. [Alcohol concentration in the coronary sinus after transarterial ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy].
Klein N; Mende M; Hagendorff A; Neugebauer A; Pfeiffer D
Dtsch Med Wochenschr; 2000 May; 125(19):579-83. PubMed ID: 11320715
[TBL] [Abstract][Full Text] [Related]
20. Delayed occurrence of complete heart block after ethanol septal ablation for hypertrophic obstructive cardiomyopathy.
Poyet R; Quilici J; Cuisset T; Bali L; Ansaldi S; Prévost S; Habib G; Bonnet JL
Int J Cardiol; 2011 Mar; 147(2):e32-4. PubMed ID: 19232758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
